[Home ] [Archive]    
:: Main About journal Editorial Board Current Issue Archive Submit an article Site Map Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Editorial Board::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 12, Issue 4 (12-2023) ::
Int J Med Invest 2023, 12(4): 67-81 Back to browse issues page
Neutrophil-To-Lymphocyte Ratio In Patients With COVID-19 Infection: A Narrative Review
Danial Soltani , Amirhossein Mohammadzadeh , Behnaz Hatami *
Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:   (221 Views)
Coronavirus disease 2019 (COVID-19), a contagious illness, has been quickly spreading throughout the world and continues to pose a danger to public health on a worldwide scale. It is essential to diagnose potentially serious or critical patients immediately and provide targeted patients with prompt therapy because patients with critical or severe cases have poor prognoses. Current biomarkers cannot reliably predict the severity of COVID-19 infection; thus, we need surrogate indicators to determine the severity of COVID-19 and forecast its progression. The neutrophil-to-lymphocyte ratio (NLR) is a new biomarker that has been linked to inflammation and prognosis in a variety of diseases. In this narrative review, we investigated the NLR's diagnostic and prognostic validity in patients with COVID-19 infection.
Keywords: Neutrophil-to-lymphocyte ratio, COVID-19, Coronavirus, Diagnosis, Prognosis
Full-Text [PDF 455 kb]   (123 Downloads)    
Type of Study: Review | Subject: General
Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Soltani D, Mohammadzadeh A, Hatami B. Neutrophil-To-Lymphocyte Ratio In Patients With COVID-19 Infection: A Narrative Review. Int J Med Invest 2023; 12 (4) :67-81
URL: http://intjmi.com/article-1-1089-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 4 (12-2023) Back to browse issues page
International Journal of Medical Investigation
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645